Platinum-based alkylating agent and nucleoside analog

This page covers all Platinum-based alkylating agent and nucleoside analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 2 pipeline (1)

• Cisplatin and Gemcitabine · Delcath Systems Inc. · Oncology
  Cisplatin is a platinum-based alkylating agent that cross-links DNA, thereby inhibiting DNA replication and transcription. Gemcitabine is a nucleoside analog that inhibits DNA synthesis by causing DNA strand breaks.

Patent intelligence

• platinum based alkylating agent and nucleoside analog patent landscape — aggregated cliff calendar, attackable patents, originator estates